Voyager Therapeutics VYGR
NASDAQ VYGR
$1.76 -0.07 (-3.56%)
At close: Nov 11, 2026 · 4:00 PM EST

Voyager Therapeutics (VYGR) Return on Sales [ROS] (2014 - 2026)

Updated

Voyager Therapeutics (VYGR) recorded Return on Sales [ROS] of -824.75% in Q2 2026, down 120.42 percentage points from -704.33% a year earlier but up 339.48 percentage points from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Return on Sales [ROS] (2014 - 2026) Analysis & Trends

On a TTM basis, Voyager Therapeutics' Return on Sales [ROS] came in at -339.32% as of Jun 30, 2026, down 49.70 percentage points year-over-year; for FY2025, it came in at -326.56%, down 222.45 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -342.56 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -104.11% in FY2024 (-152.91 pp), 48.80% in FY2023 (+173.08 pp), -124.27% in FY2022 (+72.49 pp) and -196.76% in FY2021 (-212.76 pp).
  • Quarterly Return on Sales [ROS] has ranged from -3244.68% in Q1 2022 to 81.66% in Q1 2023 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in two of the last eight quarters, with an average year-over-year change of -212.41 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 3326.34 percentage points in Q1 2023, against a drop of 2851.06 percentage points in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1164.23% (Q1 2026), -195.17% (Q4 2025) and -228.31% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Voyager Therapeutics 113.78 Mn -447.29 Mn - -658.25%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -658.25%
Jun 30, 2026 -824.75%
Mar 31, 2026 -1,164.23%
Dec 31, 2025 -195.17%
Sep 30, 2025 -228.31%
Jun 30, 2025 -704.33%
Mar 31, 2025 -533.74%
Dec 31, 2024 -610.05%
Sep 30, 2024 -55.95%
Jun 30, 2024 -50.76%
Mar 31, 2024 -82.92%
Dec 31, 2023 60.03%
Sep 30, 2023 -639.51%
Jun 30, 2023 -518.90%
Mar 31, 2023 81.66%
Dec 31, 2022 -124.28%
Sep 30, 2022 35.15%
Jun 30, 2022 -2,720.08%
Mar 31, 2022 -3,244.68%
Dec 31, 2021 20.31%
API Access

Voyager Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VYGR&period=max&api_key=YOUR_API_KEY